Back to top
more

Canopy Growth (CGC)

(Delayed Data from NSDQ)

$1.38 USD

1.38
19,158,479

+0.02 (1.47%)

Updated Sep 18, 2025 04:00 PM ET

After-Market: $1.36 -0.02 (-1.45%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.64%
2Buy17.83%
3Hold9.69%
4Sell5.29%
5Strong Sell2.54%
S&P50011.29%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

F Value C Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (98 out of 245)

Industry: Medical - Products

Zacks News

Ryan McQueeney headshot

Tesla Bull Sells (and Buys Again?) & Dow Rallies Near Highs | Free Lunch

Ryan McQueeney highlights the Dow's rally toward all-time highs on the back of strength from financial stocks. He also touches on news related to marijuana producers and reported activist interest in casino giant MGM. Later, the host calls Brian Bolan, a noted Tesla bull, to discuss a major shift in his sentiment for the electric car company.

    Ryan McQueeney headshot

    Marijuana Stocks Soar Again As Wall Street Eyes U.S. Imports

    Shares of several popular Canadian marijuana producers--including Tilray (TLRY), Canopy Growth (CGC), and Cronos Group (CRON)--were surging once again on Wednesday as Wall Street grows ever-more bullish on the prospects of legalization and U.S. imports.

      Neena Mishra headshot

      Why Marijuana Stocks and ETF are Soaring

      Pot stocks are hot but also very volatile, here is what investors need to know

        Ryan McQueeney headshot

        Will Disruptive Technology Play a Role in the Marijuana Industry?

        Ryan McQueeney discusses the intersection of disruptive technology and the budding marijuana industry, ultimately concluding that investors should remember what they've learned about investing in other forms of new tech as it becomes a bigger factor in the cannabis business.

          Zacks Equity Research

          Company News For Sep 18, 2018

          Companies In The News are: AMZN,CGC,KO,MDP

            Zacks Equity Research

            Is Coca-Cola's Cannabis Venture a Solution to Its Problems?

            Coca-Cola (KO) explores the cannabis-infused drinks market to combat the fading popularity of sugary carbonated sodas.

              Neena Mishra headshot

              Marijuana Stocks and ETF: What Investors Need to Know

              Pot stocks are hot but also very volatile, here is what investors need to know.

                Sweta Killa headshot

                ETFs & Stocks to Tap Marijuana Boom

                Investors seeking to tap the ongoing green rush may consider these ETFs and stocks.

                  Zacks Equity Research

                  Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: What You Should Know

                  Canopy Growth Corporation (CGC) closed at $51.05 in the latest trading session, marking a -0.31% move from the prior day.

                    Zacks Equity Research

                    Canopy Growth Corporation (CGC) Dips More Than Broader Markets: What You Should Know

                    Canopy Growth Corporation (CGC) closed the most recent trading day at $51.90, moving -1.53% from the previous trading session.

                      Sanghamitra Saha headshot

                      Top and Flop ETFs of August

                      Inside the top and worst performing ETFs of August.

                        Sanghamitra Saha headshot

                        Top ETF Stories of August

                        Inside the eye-catching ETF events of August.

                          Sweta Killa headshot

                          5 Best Stocks of the Top ETF of August

                          Cannabis-related ETFMG Alternative Harvest ETF (MJ) is the best-performing ETF of August, gaining 22.5% and attracting $22 million in AUM.

                            Zacks Equity Research

                            Canopy Growth (CGC) Jumps: Stock Rises 7.4%

                            Canopy Growth (CGC) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

                              Benjamin Rains headshot

                              What Investors Need to Know About Investing In Marijuana Stocks

                              Marijuana has come a long way since California legalized cannabis for medicinal use back in 1996. Today, the industry and marijuana look to be on the cusp of unprecedented acceptance, with major international giants investing billions into publicly traded cannabis companies. So let's take a look at what investors need to know about the marijuana industry and how to invest in the future of pot.

                                Sanghamitra Saha headshot

                                Pot Stocks Are on a High: Play These Cannabis ETFs

                                Beverage companies are eyeing the cannabis market aggressively for making pot-infused drinks. Play the binge with these ETFs.

                                  Zacks Equity Research

                                  Zacks Industry Outlook Highlights: Anheuser-Busch, Constellation, Canopy Growth and Brown-Forman.

                                  Zacks Industry Outlook Highlights: Anheuser-Busch, Constellation, Canopy Growth and Brown-Forman.

                                    Zacks Equity Research

                                    Alcohol Outlook: Soft Beer Demand & High Costs to Hurt

                                    The Beverages - Alcohol industry is in the doldrums due to softness in the beer segment, the consumers' shift to healthy options and higher aluminum costs, which is hurting investors' confidence.

                                      Sanghamitra Saha headshot

                                      Follow Constellation Brands, Bet Big on Cannabis ETFs

                                      Cannabis ETFs take a leap as Constellation Brands boosted its share in cannabis company Canopy Growth.

                                        Ryan McQueeney headshot

                                        Pot Stocks, Tesla, Pepsi Buys SodaStream, & Retail Earnings | Free Lunch

                                        Ryan McQueeney touches on today's mixed news related to Tesla and Pepsi's acquisition of SodaStream. He also investigates the recent momentum of popular cannabis stocks like Canopy Growth, Cronos Group, and Tilray. Later, the host previews upcoming earnings reports from the retail sector.

                                          Zacks Equity Research

                                          Canopy Growth (CGC) in Focus: Stock Moves 9.2% Higher

                                          Canopy Growth (CGC) shares rose more than 9% in the last trading session, amid huge volumes.

                                            Zacks Equity Research

                                            Constellation Brands Invests in Cannabis, Expands Canopy Stake

                                            Constellation Brands (STZ) expands its stake in Canada's Canopy Growth Corporation to 38% through an additional $5-billion investment.

                                              Ryan McQueeney headshot

                                              Buffett Buys More Apple, GE Falls Further, & Turkey Weighs on Stocks | Free Lunch

                                              Ryan McQueeney discusses the morning's top market headlines, including the effect of the Turkish crisis on U.S. stocks, GE's historic low point, Corona's new marijuana investment, and earnings from retail giant Macy's. Later, he checks in with Warren Buffett's latest holdings and discusses the investing icon's take in Apple.

                                                Benjamin Rains headshot

                                                CRON, CGC Sink Ahead of Earnings: What To Watch From These Pot Stocks

                                                Recreational marijuana is now legal in Canada as well as a number of states in the U.S. Companies have raced to get in on the multibillion-dollar a year industry, so let's see how two of the bigger pure-play pot stocks, Cronos Group (CRON) and Canopy Growth (CGC), are projected to perform Tuesday.

                                                  Zacks Equity Research

                                                  Can Tenet Healthcare (THC) Keep Earnings Beat Alive in Q2?

                                                  Tenet Healthcare (THC) is likely to repeat its success story in Q2 on the back of a strong performance at the Conifer segment as well as its key initiatives.